Bausch Health Companies Inc. (BHC:TSX) closed at $9.03 on October 23, 2026, down 0.66% on the day. The stock trades 18.5% below its 52-week high of $11.08 and 48.0% above its 52-week low of $6.10. Over the past year, it gained 3.8%. Bausch Health Companies Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, BHC closed higher on 122 days (48%). Its best day was July 30, 2026 (+28.51%) and its worst was January 23, 2026 (-11.03%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.
Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in four segments: Bausch+Lomb and international (55% of revenue), Salix pharmaceuticals (25%), ortho dermatology (6%), and diversified products (14%), and approximately 13% of revenue is attributable to non-U.S. markets. Bausch is the market leader in consumer visioncare in India and China, and the fourth-largest visioncare company by sales in the United States.
Find more stocks like BHC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.